
Shidlovski/iStock via Getty Images
Ocular Therapeutix (NASDAQ:OCUL) rose 6% amid takeover speculation.
There's speculation that a French pharmaceutical company is circling Ocular Therapeutix (NASDAQ:OCUL), according to traders, who cited a Betaville "uncooked" alert that was circulating on Friday.
Some people following the matter have